Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors
Status:
Withdrawn
Trial end date:
2018-05-17
Target enrollment:
Participant gender:
Summary
Establish safety and toxicity profile and preliminary response rate of CPI-0610 in MPNST
patients and correlate response with pharmacodynamics markers and BET inhibition.